Cargando…
Reducing Malignant Ascites and Long-Term Survival in a Patient with Recurrent Gastric Cancer Treated with a Combination of Docetaxel and Mistletoe Extract
Recurrent gastric cancer with peritoneal seeding is associated with poor overall survival. A 71-year-old man with advanced gastric cancer underwent radical total gastrectomy (stage IIIb, T4b N1 M0). Abdomino-pelvic computed tomography performed 7 months after surgery revealed increased ascites with...
Autor principal: | Oh, Sung Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265700/ https://www.ncbi.nlm.nih.gov/pubmed/32518549 http://dx.doi.org/10.1159/000507282 |
Ejemplares similares
-
Survival of cancer patients treated with mistletoe extract (Iscador): a systematic literature review
por: Ostermann, Thomas, et al.
Publicado: (2009) -
Emerging roles of mistletoes in malignancy management
por: Patel, Seema, et al.
Publicado: (2013) -
Survival of Cancer Patients Treated with Non-Fermented Mistletoe
Extract: A Systematic Review and Meta-Analysis
por: Loef, Martin, et al.
Publicado: (2022) -
Third-line docetaxel chemotherapy for recurrent and metastatic gastric cancer
por: Lee, Ji Hyun, et al.
Publicado: (2013) -
Difficulties and Perspectives of Immunomodulatory Therapy with Mistletoe Lectins and Standardized Mistletoe Extracts in Evidence-Based Medicine
por: Hajtó, Tibor, et al.
Publicado: (2011)